Literature DB >> 2266559

DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein.

R Hoess1, K Abremski, S Irwin, M Kendall, A Mack.   

Abstract

The Cre protein of bacteriophage P1 is a 38.5 kDa site-specific recombinase that belongs to the Int family of recombination proteins. Cre acts by binding specifically to a 34 base-pair sequence, lox, where it carries out recombination. A limited chymotryptic digest of Cre resulted in two fragments of sizes 25 and 13.5 kDa, respectively. The sequence of the amino terminus of the purified 25 kDa peptide demonstrates that this peptide represents the carboxyl-terminal portion of the Cre protein. A truncated version of the cre gene was constructed which produces only the 25 kDa peptide. The 25 kDa peptide is capable of specific binding to the lox site, but binds at lower affinity than does wild-type Cre. Footprinting with Fe-EDTA indicates that the 25 kDa peptide protects the inverted repeats of the lox site but shows only partial protection of the spacer region. This is in contrast to the footprint obtained with wild-type Cre which protects the entire spacer region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266559     DOI: 10.1016/S0022-2836(99)80007-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  A new approach for the identification and cloning of genes: the pBACwich system using Cre/lox site-specific recombination.

Authors:  S Choi; D Begum; H Koshinsky; D W Ow; R A Wing
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

2.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  Crystal structure of a wild-type Cre recombinase-loxP synapse reveals a novel spacer conformation suggesting an alternative mechanism for DNA cleavage activation.

Authors:  Eric Ennifar; Joachim E W Meyer; Frank Buchholz; A Francis Stewart; Dietrich Suck
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

4.  Stoichiometry of the Cre recombinase bound to the lox recombining site.

Authors:  A Mack; B Sauer; K Abremski; R Hoess
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

5.  Trans cooperativity by a split DNA recombinase: the central and catalytic domains of bacteriophage lambda integrase cooperate in cleaving DNA substrates when the two domains are not covalently linked.

Authors:  Srisunder Subramaniam; Hari B Kamadurai; Mark P Foster
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

6.  A chimeric Cre recombinase with regulated directionality.

Authors:  David Warren; Gurunathan Laxmikanthan; Arthur Landy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

7.  Similarities and differences among 105 members of the Int family of site-specific recombinases.

Authors:  S E Nunes-Düby; H J Kwon; R S Tirumalai; T Ellenberger; A Landy
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

8.  DNA binding induces a cis-to-trans switch in Cre recombinase to enable intasome assembly.

Authors:  Aparna Unnikrishnan; Carlos Amero; Deepak Kumar Yadav; Kye Stachowski; Devante Potter; Mark P Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-23       Impact factor: 11.205

9.  Inhibition of recombinant human immunodeficiency virus type 1 replication by a site-specific recombinase.

Authors:  C C Flowers; C Woffendin; J Petryniak; S Yang; G J Nabel
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  Regulation of Cre recombinase by ligand-induced complementation of inactive fragments.

Authors:  Nicolas Jullien; François Sampieri; Alain Enjalbert; Jean-Paul Herman
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.